Kolon Life Science Inc. (KOSDAQ:102940)

South Korea · Delayed Price · Currency is KRW

60,600

-400 (-0.66%)

Apr 29, 2026, 3:30 PM KST

Revenue by Segment

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2012	FY 2011	FY 2010
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '12 Dec 31, 2012	Dec '11 Dec 31, 2011	Dec '10 Dec 31, 2010
Chemical Business Division			124.38B	145.47B	164.40B	155.03B		-
Chemical Business Division Growth			-14.50%	-11.51%	6.04%	-		-
Bio Business Division			254.86M	16.11B	1.09B	-25.62B		-
Bio Business Division Growth			-98.42%	1384.13%	-	-		-
Total			124.64B	161.58B	165.49B	129.41B		-
Total Growth			-22.86%	-2.36%	27.87%	-		-

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2012	FY 2011	FY 2010
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '12 Dec 31, 2012	Dec '11 Dec 31, 2011	Dec '10 Dec 31, 2010
Korea			16.54B	19.92B	45.33B	39.58B		141.25B
Korea Growth			-16.94%	-56.06%	14.54%	-		20.53%
Japan			62.68B	74.64B	76.82B	51.07B		-
Japan Growth			-16.02%	-2.84%	50.43%	-		-
Europe			7.28B	10.94B	6.66B	7.56B		-
Europe Growth			-33.45%	64.15%	-11.88%	-		-
Asia/Pacific			28.15B	48.75B	33.64B	26.54B		-
Asia/Pacific Growth			-42.27%	44.91%	26.75%	-		-
Other			9.99B	7.34B	3.02B	4.66B		-
Other Growth			36.15%	142.75%	-35.15%	-		-
Total			124.64B	161.58B	165.49B	129.41B		141.25B
Total Growth			-22.86%	-2.36%	27.87%	-		20.53%

Source: S&P Global Market Intelligence.